Summit Therapeutics rises as co-CEOs buy nearly $12M worth of company stock
Source: SeekingAlpha
2025-09-12 09:57:57 ET
More on Summit Therapeutics
- Summit Therapeutics (SMMT) WCLC Update Call
- Summit Therapeutics (SMMT) WCLC Update Call (Transcript)
- Summit Therapeutics: Dethroning Merck Was Never Going To Be Straightforward
- Biggest stock movers Monday: RAPP, MCRB, SATS, QS, SMMT and more
- Summit shares fall following lung cancer drug trial results for Ivonescimab
Read the full article on Seeking Alpha
For further details see:
Summit Therapeutics rises as co-CEOs buy nearly $12M worth of company stock
Akeso
NASDAQ: AKESF
AKESF Trading
-0.8% G/L:
$16.567 Last:
250 Volume:
$16.567 Open:
